Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Developmental screening at 18 months using the Nipissing District Developmental Screen.

Paediatrics & child health·2025
Same author

Engineered protein inhibitors for precise targeting of matrix metalloproteinases.

Trends in biochemical sciences·2025
Same author

ProBASS-a language model with sequence and structural features for predicting the effect of mutations on binding affinity.

Bioinformatics (Oxford, England)·2025
Same author

Proximal Co-Translation Facilitates Detection of Weak Protein-Protein Interactions.

International journal of molecular sciences·2024
Same author

Engineered TIMP2 with narrow MMP-9 specificity is an effective inhibitor of invasion and proliferation of triple-negative breast cancer cells.

The Journal of biological chemistry·2024
Same author

Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide Extension.

Biomolecules·2024

相关实验视频

Updated: Jan 13, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.9K

专门针对MMP-9的工程N-TIMP2变种表现出强大的抗质母细胞瘤活性.

Mark Feldman1, Naama Rotenberg1, Julia M Shifman1

  • 1Department of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.

Biomolecules
|October 29, 2025
PubMed
概括

一种工程N-TIMP2变体 (REY) 有效地准矩阵金属蛋白酶-9 (MMP-9),抑制质母细胞瘤 (GB) 细胞的入侵和传播. 这种高度特异性的抑制剂显示出作为一种新型治疗侵略性脑癌的前景.

关键词:
MMP 抑制剂的使用质母细胞瘤是什么矩阵金属蛋白酶9 (MMP-9) 的作用.蛋白质工程工程 蛋白质工程基因金属蛋白酶2 (TIMP-2) 的组织抑制剂.

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.8K
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.8K

相关实验视频

Last Updated: Jan 13, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.9K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.8K
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.8K

科学领域:

  • 在瘤学瘤学.
  • 生物化学 生物化学
  • 分子生物学分子生物学

背景情况:

  • 质母细胞瘤 (GB) 是一种具有高复发率的侵袭性脑癌,原因是侵袭性瘤细胞.
  • 矩阵金属蛋白酶-9 (MMP-9) 对GB的进展,侵入性和预后不佳至关重要.
  • 向MMP-9为质母细胞瘤提供了潜在的治疗策略.

研究的目的:

  • 为了评估工程N-TIMP2变体 (REY) 作为MMP-9抑制剂的疗效和毒性.
  • 为了比较工程 REY 变体与野生型 N-TIMP2.2 的性能.
  • 评估REY在质母细胞瘤治疗中的治疗潜力.

主要方法:

  • 在体外测定使用成年质母细胞瘤U251和正常Vero细胞.
  • 评估殖民地形成,细胞入侵和球形传播.
  • 对MMP-9的细胞毒性和特异性的评估.

主要成果:

  • 在纳米分子度下,REY显著抑制了质母细胞细胞殖民地形成和入侵.
  • REY显著减少了球形状的扩散,表明侵入性减少.
  • 工程 REY 变种对 MMP-9 具有很高的特异性,表现优于野生型 N-TIMP2,并且对健康细胞没有细胞毒性.

结论:

  • MMP-9是质母细胞瘤的一个可行的治疗点.
  • 工程N-TIMP2变体 (REY) 是一种强效和选择性的MMP-9抑制剂.
  • REY在质母细胞瘤治疗中显示出显著的治疗潜力,具有有利的安全性.